TRINA SOLAR – the world’s largest manufacturer of photovoltaic modules – interested in XTPL technology

Trina Solar – a company listed on the New York Stock Exchange, specializing in the production of photovoltaic modules based on crystalline silicon – sent a letter of intent, in which it confirms its serious interest in the technology developed by XTPL.

– The XTPL technology, allowing to print very narrow electrically conductive lines, can have a significant impact on the global technology of producing silicon solar cells, since it enables a significant reduction of power losses associated with metallization of these solar cells. Now it is necessary to further develop the XTPL technology from a laboratory scale to a high level of production readiness. The technology, in case of a successful scaling to industrial conditions, fits very well into the so-called technological roadmap for silicon solar cells at Trina Solar. We look forward to working with the XTPL team – says Dr. Pierre Verlinden, senior vice president and chief scientist at Trina Solar.

XTPL with patent application and a grant from PARP

The technology of making ultra-thin, electrically conductive lines, developed by Polish physicists – Filip Granek and Zbigniew Rozynek – has been protected by closing the patent application. The XTPL company has received a grant from the Polish Agency for Enterprise Development (PARP) to conduct the process of global patent protection for its unique technology.
XTPL patent application was filed on March 22, 2016 in the UK. The patent application was prepared in collaboration with a renowned London-based law firm specializing in intellectual property protection in the area of XTPL’s fields of application.

– The London lawyers helped us to prepare not only a very good text of the patent application, but the whole patenting strategy for the future. In March we closed the application. The scope of patent protection in the first place will the UK, but over the next months and years will be extended globally. In the application for a grant for the patenting process we have identified 40 countries. Among them are, among others, China, Israel, Japan, Germany, United States, Taiwan, the United Arab Emirates and Australia – explains Dr. Filip Granek, co-founder of XTPL.

XTPL applied for funding for activities related to the protection of industrial property in a program run by PARP, which supports enterprises from the SME sector in the process of obtaining such protection under the national, regional, EU or international level. XTPL’s application was assessed positively and the company received a grant in the amount of nearly PLN 400 000.

– We are pleased that such an institution as the Polish Agency for Enterprise Development believed in our project and trusted our technology. Support of external companies and organizations assures us that we have chosen the proper way of development of our invention – adds Dr. Granek.

XTPL is a technology company founded by eminent Polish scientists. The company develops optically transparent and electrically conductive layers, which can be applied as transparent electrodes in thin-film solar cells and liquid crystal displays (LCD).

Pregnabit recognized at the International Conference Med-e-Tel in Luxembourg

Med-e-Tel is a prestigious event organized by the International Society for Telemedicine & eHealth (ISfTeH) in Switzerland. Its purpose is the international exchange of knowledge and experience in the field of Telemedicine and e-Health. The event was attended by experts from around the world. Netsmedic team presented Pregnabit during session speeches, and in the exhibition section. Our solution aroused great interest and enabled us to establish many contacts that open the possibility of cooperation also on other continents.

Nestmedic closes another round of financing, acquiring new investors

Very quick product development, positive feedback of professionals and an attractive business model encouraged further private investors to invest in Nestmedic. We are very happy not only to increase the capabilities of the company, but also the profile of investors, their vast experience in international business.

“This is a proof of confidence in our team, technology and business model. It is an expression of the rapidly growing interest in telemedicine, whose time has come, and which has a very promising growth prospects. We are very happy, now we shift another gear and accelerate” – says Patrycja Wizińska-Socha, CEO Nestmedic.

Another round will start soon, interested investors please visit Pregnabit – For investors

Contact us